Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii

Ralph P Miech1

  • 1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Brown University, 174 Meeting St., Providence, RI 02912-9107, USA. Ralph_Miech@brown.edu

Abstract

Insights

Mifepristone use in medical abortions may increase the risk of lethal septic shock from Clostridium sordellii by impairing the immune system. This drug interferes with cortisol and cytokine responses, allowing infection to spread rapidly.

Area of Science:

  • Reproductive Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Medical abortion utilizes mifepristone, a progesterone and glucocorticoid receptor antagonist.
  • Rare but severe cases of septic shock due to Clostridium sordellii have been associated with mifepristone use.
  • Understanding the pathophysiology is crucial for patient safety and risk mitigation.

Purpose of the Study:

  • To elucidate the role of mifepristone in the development of fulminant and lethal septic shock caused by Clostridium sordellii.
  • To explore the immunological mechanisms underlying mifepristone-associated septic shock.

Main Methods:

  • Comprehensive literature search of MEDLINE, PubMed, and Google Scholar (1984-2005).
  • Inclusion of all relevant articles detailing the pathophysiology of mifepristone-induced septic shock by C. sordellii.
  • Synthesis of information on drug mechanisms and infectious agent toxins.

Main Results:

  • Mifepristone disrupts cortisol and cytokine regulation by blocking progesterone and glucocorticoid receptors.
  • This disruption impairs the innate immune system, compromising defenses against endometrial C. sordellii infection.
  • Combined effects of mifepristone's actions and C. sordellii toxins lead to rapid, lethal septic shock.

Conclusions:

  • Mifepristone's mechanism of action theoretically promotes C. sordellii infection and septic shock development.
  • The drug intensifies inflammatory cytokine responses, contributing to fulminant and lethal septic shock.
  • Further research into the interaction between mifepristone and C. sordellii is warranted.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...